title: Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.
abstract: This pilot study sought to characterize typical nonmedical oxycodone use in the New York Metropolitan area. Accordingly, a clinical interview was administered to 25 intranasal (IN) and 25 intravenous (IV) oxycodone abusers to capture demographics and patterns of use within the region. IN and IV abusers shared a number of similar characteristics including age, proportion of men and women, criminal history, drug use history, and current recreational drug use. However, the two populations also differed in a number of aspects. IV oxycodone users had lower rates of employment, earlier onset of illicit drug use, and more current heroin use. Although IN users reported somewhat more frequent use of oxycodone weekly, IV users were more likely to supplement their oxycodone use with other opioid drugs, most notably heroin. Additional research is needed to confirm these observed differences, yet these data may assist treatment efforts by providing information to guide targeted treatment and population-specific interventions.
authors.affiliation: Division on Substance Abuse, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA. Jonesje@pi.cpmc.columbia.edu
authors.forename: Jermaine D
authors.initials: JD
authors.lastname: Jones
authors.forename: Suzanne K
authors.initials: SK
authors.lastname: Vosburg
authors.forename: Jeanne M
authors.initials: JM
authors.lastname: Manubay
authors.forename: Sandra D
authors.initials: SD
authors.lastname: Comer
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D017668:Age of Onset; D003415:Crime / Q000706:statistics & numerical data; D003710:Demography / Q000706:statistics & numerical data; D055030:Drug Users / Q000523:psychology*; D005260:Female; D006801:Humans; D008297:Male; D009519:New York City; D009293:Opioid-Related Disorders / Q000523:psychology*; D010098:Oxycodone / Q000008:administration & dosage / Q000009:adverse effects*; D015819:Substance Abuse, Intravenous / Q000523:psychology*; D013375:Substance Withdrawal Syndrome / Q000523:psychology
chemical_list: D010098:Oxycodone